Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16122767 | Etravirine (TMC125) | 269055-15-4 | 98% | -cas-269055-15-4.png) |
| Etravirine (TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used | ||||
| 16122763 | Efavirenz | 154598-52-4 | 98% |  |
| Efavirenz is a synthetic non-nucleoside reverse transcriptase (RT) inhibitor with ant | ||||
| 16122762 | Epoxomicin | 134381-21-8 | 98% |  |
| Epoxomicin is a selective proteasome inhibitor with anti-inflammatory activity, inhib | ||||
| 16122734 | EAI045 | 1942114-09-1 | 98% |  |
| EAI045 is an allosteric inhibitor that targets selected drug-resistant EGFR mutants b | ||||
| 16122703 | ETC-1002 | 738606-46-7 | 98% |  |
| ETC-1002,also known as Bempedoic acid, is an orally available, once-daily LDL-C lower | ||||
| 6111502 | ERK5-IN-1 | 1234479-76-5 | 98% |  |
| ERK5-IN-1 exhibits potent inhibition of ERK5 with cellular EC50 values of 0.19 M and | ||||
| 61124 | Etretinate | 54350-48-0 | 98% |  |
| Etretinate is an oral aromatic retinoid acid which is effective in psoriasis and othe | ||||
| 6111007 | EW-7197 | 1352608-82-2 | 98% |  |
| EW-7197 is a highly potent, selective, and orally bioavailable TGF- receptor ALK4/ALK | ||||
| 611825 | ETP-46321 | 1252594-99-2 | 98% |  |
| ETP-46321 is a potent and orally bioavailable PI3K / inhibitor with IC50 of 2.3/14.2 | ||||
| 161009015 | ETP-46464 | 1345675-02-6 | 98% by HPLC |  |
| ATR,Bioactive Small Molecule Alphabetical Index,Bioactive Small Molecules,Cell Biolog | ||||
| 16090201 | EPZ020411 | 1700663-41-7 | 98% by HPLC | |
| EPZ020411 is a potent and selective inhibitor of PRMT6 with IC50 of 10 nM, has 10 fol | ||||
| 16071025 | Elesclomol | 488832-69-5 | 98% by HPLC |  |
| Elesclomol, also known as STA-4783, is a HSP-90 Inhibitor, and is a small-molecule bi | ||||
| 16071024 | Emricasan | 254750-02-2 | 98% |  |
| Emricasan (IDN-6556, PF-03491390) is a potent irreversible pan-caspaseinhibitor with | ||||
| 16071015 | EPZ031686 | 1808011-22-4 | 98% by HPLC | |
| EPZ031686 | ||||
| 16071011 | Etelcalcetide | 1334237-71-6 | 98% by HPLC | |
| Etelcalcetide, also known as AMG 416 and KAI-4169, is a D-amino peptide calcimimetic | ||||
| 16071009 | Etamicastat HCl salt | 677773-32-9 | 98% by HPLC |  |
| Etamicastat, also known as BIA 5-453, is a potent, reversible, peripherally selective | ||||
| 16062803 | Entospletinib (GS-9973) | 1229208-44-9 | 98% by HPLC | -cas-1229208-44-9.png) |
| Entospletinib, also known as GS-9973, is a highly selective and orally efficacious Sy | ||||
| 1661901 | EL-102(EL102) | 1233948-61-2 | 98% by HPLC | -cas-1233948-61-2.png) |
| EL102 is a novel toluidine sulphonamide.EL102 has showedthe potential efficacy in pre | ||||
| 16061503 | Etidocaine Hydrochloride | 36637-19-1 | 98% by HPLC |  |
| ()-N-(2,6-dimethylphenyl)-2-(ethylpropylamino)butyramide monohydrochloride ;Etidocain | ||||
| 16061502 | Etbicyphat | 1005-93-2 | 98% by HPLC |  |
| Etbicyphat,1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphate | ||||
| 16060602 | eptapirone | 179756-58-2 | 98% by HPLC |  |
| eptapirone | ||||
| 16060301 | ETC-159 | 1638250-96-0 | 98% by HPLC |  |
| ETC-159, also known as ETC-1922159, is a potent, selective and orally available PORCN | ||||
| 012005 | Eluxadoline | 864821-90-9 | 98% |  |
| Eluxadoline is an orally active mixed opioid receptor (OR) agonist opioid receptor | ||||
| 011922 | Evatanepag | 223488-57-1 | 98% |  |
| Coming soon! | ||||
| 011910 | Eperezolid | 165800-04-4 | 98% |  |
| Eperezolid is a oxazolidinone antibacterial agent. | ||||
| 011303 | Emapunil | 226954-04-7 | 98% |  |
| Emapunil is a translocator protein [TSPO (18 kDa)] ligand. | ||||
| 011122 | Enzastaurin | 170364-57-5 | 98% |  |
| Enzastaurin is a potent PKC selective inhibitor with IC50 of 6 nM, 6- to 20-fold sele | ||||
| 010608 | EPZ004777 | 1338466-77-5 | 98% |  |
| EPZ004777 is a potent, selective DOT1L inhibitor with IC50 of 0.4 nM. | ||||
| 010411 | Elbasvir | 1444832-51-2 | 98% |  |
| Elbasvir is a HCV NS5A inhibitor, which is currently in phase 2b clinical trials as | ||||
| 010406 | Estradiol | 50-28-2 | 98% |  |
| Estradiol is the 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl | ||||